Beneficial effects of calcitriol on hypertension, glucose intolerance, impairment of endothelium-dependent vascular relaxation, and visceral adiposity in fructose-fed hypertensive rats

PLoS ONE

Volumn 10, Issue 3, 2015, Pages

  Chou, Chu Lin ^a   Pang, Cheng Yoong ^a   Lee, Tony J F ^a,b   Fang, Te Chao ^c,d  

^a TZU CHI UNIVERSITY   (Taiwan)

^b SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; CALCITRIOL; CALCIUM ION; CHOLESTEROL; CREATININE; FRUCTOSE; GLUCOSE; PHOSPHATE; TRIACYLGLYCEROL; VITAMIN;

ABDOMINAL OBESITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD VESSEL REACTIVITY; BODY WEIGHT; CALCIUM BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIETARY INTAKE; DRUG EFFICACY; FEEDING; GLUCOSE BLOOD LEVEL; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE; HYPERTENSION; INTRAABDOMINAL FAT; MALE; NONHUMAN; PHOSPHATE BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; VASCULAR DISEASE; VASODILATATION; ANIMAL; BLOOD PRESSURE; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECTS; GLUCOSE TOLERANCE TEST; METABOLISM; OBESITY; OBESITY, ABDOMINAL; PATHOLOGY; WISTAR KYOTO RAT;

RATTUS; ZEA MAYS;

ADIPOSITY; ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; BODY WEIGHT; CALCITRIOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FRUCTOSE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HYPERTENSION; MALE; OBESITY, ABDOMINAL; RATS; RATS, INBRED WKY; VASODILATION; VITAMINS;

EID: 84925068489     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0119843     Document Type: Article

References (68)

1. Mellanby E. Nutrition Classics. The Lancet 1:407-12, 1919
2. An experimental investigation of rickets. Edward Mellanby. Nutr Rev. 1976;34: 338-340
3. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357: 266-281. PMID: 17634462
4. Baz-Hecht M, Goldfine AB. The impact of vitamin D deficiency on diabetes and cardiovascular risk. Curr Opin Endocrinol Diabetes Obes. 2010; 17: 113-119. doi: 10.1097/MED.0b013e3283372859 PMID: 20150805
5. Pilz S, Tomaschitz A, Ritz E, Pieber TR. Vitamin D status and arterial hypertension: A systematic review. Nat Rev Cardiol. 2009; 6: 621-630. doi: 10.1038/nrcardio.2009.135 PMID: 19687790
6. Tamez H, Thadhani RI. Vitamin D and hypertension: An update and review. Curr Opin Nephrol Hypertens. 2012; 21: 492-499. doi: 10.1097/MNH.0b013e3283557bf0 PMID: 22820371
7. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008; 117: 503-511. doi: 10.1161/CIRCULATIONAHA.107. 706127 PMID: 18180395
8. Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: A prospective study. Arch Intern Med. 2008; 168: 1174-1180. doi: 10.1001/archinte.168.11.1174 PMID: 18541825
9. Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, et al. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med. 2010; 152: 307-314. doi: 10.7326/0003-4819-152-5-201003020-00009 PMID: 20194237
10. Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: A systematic review. Eur J Clin Nutr. 2011; 65: 1005-1015. doi: 10.1038/ejcn.2011.118 PMID: 21731035
11. Soares MJ, Chan She Ping-Delfos W, Ghanbari MH. Calcium and vitamin D for obesity: A review of randomized controlled trials. Eur J Clin Nutr. 2011; 65: 994-1004. doi: 10.1038/ejcn.2011.106 PMID: 21731038
12. Johnson RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang DH, et al. Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr. 2007; 86: 899-906. PMID: 17921363
13. Hwang IS, Ho H, Hoffman BB, Reaven GM. Fructose-induced insulin resistance and hypertension in rats. Hypertension. 1987; 10: 512-516. PMID: 3311990
14. Giacchetti G, Sechi LA, Griffin CA, Don BR, Mantero F, Schambelan M. The tissue renin-angiotensin system in rats with fructose-induced hypertension: Overexpression of type 1 angiotensin II receptor in adipose tissue. J Hypertens. 2000; 18: 695-702. PMID: 10872553
15. Chou CL, Pang CY, Lee TJ, Fang TC. Direct renin inhibitor prevents and ameliorates insulin resistance, aortic endothelial dysfunction and vascular remodeling in fructose-fed hypertensive rats. Hypertens Res. 2013; 36: 123-128. doi: 10.1038/hr.2012.124 PMID: 22895064
16. Kobayashi R, Nagano M, Nakamura F, Higaki J, Fujioka Y, Ikegami H, et al. Role of angiotensin II in high fructose-induced left ventricular hypertrophy in rats. Hypertension. 1993; 21: 1051-1055. PMID: 8505091
17. Li YC, Kong J, Wei M, Chen ZF, Liu SQ, Cao LP. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest. 2002; 110: 229-238. PMID: 12122115
18. Yuan W, Pan W, Kong J, Zheng W, Szeto FL, Wong KE, et al. 1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J Biol Chem. 2007; 282: 29821-29830. PMID: 17690094
19. Wong MS, Delansorne R, Man RY, Svenningsen P, Vanhoutte PM. Chronic treatment with vitamin D lowers arterial blood pressure and reduces endothelium-dependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol. 2010; 299: H1226-1234. doi:10 .1152/ajpheart.00288.2010 PMID: 20693391
20. Wong MS, Delansorne R, Man RY, Vanhoutte PM. Vitamin D derivatives acutely reduce endotheliumdependent contractions in the aorta of the spontaneously hypertensive rat. Am J Physiol Heart Circ Physiol. 2008; 295: H289-296. doi: 10.1152/ajpheart.00116.2008 PMID: 18487433
21. Mancuso P, Rahman A, Hershey SD, Dandu L, Nibbelink KA, Simpson RU. 1,25-Dihydroxyvitamin-D3 treatment reduces cardiac hypertrophy and left ventricular diameter in spontaneously hypertensive heart failure-prone (cp/+) rats independent of changes in serum leptin. J Cardiovasc Pharmacol. 2008; 51: 559-564. doi: 10.1097/FJC.0b013e3181761906 PMID: 18496147
22. Dong J, Wong SL, Lau CW, Lee HK, Ng CF, Zhang L, et al. Calcitriol protects renovascular function in hypertension by down-regulating angiotensin II type 1 receptors and reducing oxidative stress. Eur Heart J. 2012; 33: 2980-2990. doi: 10.1093/eurheartj/ehr459 PMID: 22267242
23. Saito H, Harada S. Eldecalcitol replaces endogenous calcitriol but does not fully compensate for its action in vivo. J Steroid Biochem Mol Biol. 2014 Oct; 144 Pt A:189-96. doi: 10.1016/j.jsbmb.2013.11.013 PMID: 24291401
24. Zittermann A, Schleithoff SS, Koerfer R. Vitamin D and vascular calcification. Curr Opin Lipidol. 2007; 18: 41-46. PMID: 17218831
25. Fang TC, Huang WC. Angiotensin receptor blockade blunts hyperinsulinemia-induced hypertension in rats. Hypertension. 1998; 32: 235-242. PMID: 9719048
26. Fang TC, Huang WC. Role of angiotensin II in hyperinsulinemia-induced hypertension in rats. J Hypertens. 1998; 16: 1767-1774. PMID: 9869010
27. Chou CL, Lai YH, Lin TY, Lee TJ, Fang TC. Aliskiren prevents and ameliorates metabolic syndrome in fructose-fed rats. Arch Med Sci. 2011; 7: 882-888. doi: 10.5114/aoms.2011.25566 PMID: 22291836
28. Osaki A, Shimizu H. Peripheral administration of nesfatin-1 increases blood pressure in mice. Hypertens Res. 2014; 37: 185-186. doi: 10.1038/hr.2013.122 PMID: 24048489
29. Min LJ, Mogi M, Tsukuda K, Jing F, Ohshima K, Nakaoka H, et al. Direct Stimulation of Angiotensin II Type 2 Receptor Initiated After Stroke Ameliorates Ischemic Brain Damage. Am J Hypertens. 2014; 27: 1036-1044. doi: 10.1093/ajh/hpu015 PMID: 24572705
30. Ikeda A, Kai H, Kajimoto H, Yasuoka S, Kage M, Imaizumi T. Selective gene expression analysis of muscular and vascular components in hearts using laser microdissection method. Int J Vasc Med. 2012:863410. doi: 10.1155/2012/863410
31. Yen TH, Yang HY, Yeh YH, Chu PH, Wen CJ, Fu JF, et al. Aliskiren attenuates proteinuria in mice with lupus nephritis by a blood pressure-independent mechanism. Lupus. 2013; 22: 180-189. doi: 10.1177/ 0961203312471871 PMID: 23257405
32. Maurer AD, Eller LK, Hallam MC, Taylor K, Reimer RA. Consumption of diets high in prebiotic fiber or protein during growth influences the response to a high fat and sucrose diet in adulthood in rats. Nutr Metab. 2010; 7: 77. doi: 10.1186/1743-7075-7-77 PMID: 20920272
33. Wu LY, Juan CC, Hwang LS, Hsu YP, Ho PH, Ho LT. Green tea supplementation ameliorates insulin resistance and increases glucose transporter IV content in a fructose-fed rat model. Eur J Nutr. 2004; 43: 116-124. PMID: 15083319
34. Kinzig KP, Honors MA, Hargrave SL. Insulin sensitivity and glucose tolerance are altered by maintenance on a ketogenic diet. Endocrinology. 2010; 151: 3105-3114. doi: 10.1210/en.2010-0175 PMID: 20427477
35. Lastra G, Whaley-Connell A, Manrique C, Habibi J, Gutweiler AA, Appesh L, et al. Low-dose spironolactone reduces reactive oxygen species generation and improves insulin-stimulated glucose transport in skeletal muscle in the TG(mRen2)27 rat. Am J Physiol Endocrinol Metab. 2008; 295: E110-E116. doi: 10.1152/ajpendo.00258.2007 PMID: 18445755
36. Douard V, Sabbagh Y, Lee J, Patel C, Kemp FW, Bogden JD, et al. Excessive fructose intake causes 1,25-(OH)(2)D(3)-dependent inhibition of intestinal and renal calcium transport in growing rats. Am J Physiol Endocrinol Metab. 2013; 304: E1303-E1313. doi: 10.1152/ajpendo.00582.2012 PMID: 23571713
37. Lin HW, Liu CZ, Cao D, Chen PY, Chen MF, Lin SZ, et al. Endogenous methyl palmitate modulates nicotinic receptor-mediated transmission in the superior cervical ganglion. Proc Natl Acad Sci U S A. 2008; 105: 19526-19531. doi: 10.1073/pnas.0810262105 PMID: 19057014
38. Furuhashi M, Ura N, Takizawa H, Yoshida D, Moniwa N, Murakami H, et al. Blockade of the renin-angiotensin system decreases adipocyte size with improvement in insulin sensitivity. J Hypertens. 2004; 22: 1977-1982. PMID: 15361770
39. Huang BW, Chiang MT, Yao HT, ChiangW. The effect of high-fat and high-fructose diets on glucose tolerance and plasma lipid and leptin levels in rats. Diabetes Obes Metab. 2004; 6: 120-126. PMID: 14746577
40. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, Glushakova O, et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol. 2006; 290: F625-F631. PMID: 16234313
41. Reungjui S, Roncal CA, Mu W, Srinivas TR, Sirivongs D, Johnson RJ, et al. Thiazide diuretics exacerbate fructose-induced metabolic syndrome. J Am Soc Nephrol. 2007; 18: 2724-2731. PMID: 17855639
42. Nagai Y, Ichihara A, Nakano D, Kimura S, Pelisch N, Fujisawa Y, et al. Possible contribution of the nonproteolytic activation of prorenin to the development of insulin resistance in fructose-fed rats. Exp Physiol. 2009; 94: 1016-1023. doi: 10.1113/expphysiol.2009.048108 PMID: 19502292
43. Freundlich M, Quiroz Y, Zhang Z, Zhang Y, Bravo Y, Weisinger JR, et al. Suppression of renin-angiotensin gene expression in the kidney by paricalcitol. Kidney Int. 2008; 74: 1394-1402. doi: 10.1038/ki. 2008.408 PMID: 18813285
44. Zhou C, Lu F, Cao K, Xu D, Goltzman D, Miao D. Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int. 2008; 74: 170-179. doi: 10.1038/ki.2008.101 PMID: 18385669
45. Witham MD, Nadir MA, Struthers AD. Effect of vitamin D on blood pressure: A systematic review and meta-analysis. J Hypertens. 2009; 27: 1948-1954. doi: 10.1097/HJH.0b013e32832f075b PMID: 19587609
46. Ghiadoni L, Taddei S, Virdis A. Hypertension and endothelial dysfunction: Therapeutic approach. Curr Vasc Pharmacol. 2012; 10: 42-60. PMID: 22112351
47. Schulz E, Gori T, Munzel T. Oxidative stress and endothelial dysfunction in hypertension. Hypertens Res. 2011; 34: 665-673. doi: 10.1038/hr.2011.39 PMID: 21512515
48. Boucher BJ. Vitamin D insufficiency and diabetes risks. Curr Drug Targets. 2011; 12: 61-87. PMID: 20795936
49. de Boer IH. Vitamin D and glucose metabolism in chronic kidney disease. Curr Opin Nephrol Hypertens. 2008; 17: 566-572. doi: 10.1097/MNH.0b013e32830fe377 PMID: 18941348
50. Goltzman D. Vitamin D action: Lessons learned from genetic mouse models. Ann N Y Acad Sci. 2010; 1192: 145-152. doi: 10.1111/j.1749-6632.2009.05226.x PMID: 20392230
51. Wu K, Cappel D, Martinez M, Stafford JM. Impaired-inactivation of FoxO1 contributes to glucose-mediated increases in serum very low-density lipoprotein. Endocrinology. 2010; 151: 3566-3576. doi:10. 1210/en.2010-0204 PMID: 20501667
52. Strahorn P, Graham D, Charchar FJ, Sattar N, McBride MW, Dominiczak AF. Genetic determinants of metabolic syndrome components in the stroke-prone spontaneously hypertensive rat. J Hypertens. 2005; 23: 2179-2186. PMID: 16269959
53. Takiishi T, Gysemans C, Bouillon R, Mathieu C. Vitamin D and diabetes. Endocrinol Metab Clin North Am. 2010; 39: 419-446. doi: 10.1016/j.ecl.2010.02.013 PMID: 20511061
54. Sergeev IN, Song Q. High vitamin D and calcium intakes reduce diet-induced obesity in mice by increasing adipose tissue apoptosis. Mol Nutr Food Res. 2014; 58: 1342-1348. doi: 10.1002/mnfr. 201300503 PMID: 24449427
55. Cheng Q, Li YC, Boucher BJ, Leung PS. A novel role for vitamin D: modulation of expression and function of the local renin-angiotensin system in mouse pancreatic islets. Diabetologia. 2011; 54: 2077-2081. doi: 10.1007/s00125-011-2100-1 PMID: 21424540
56. Maestro B, Campion J, Davila N, Calle C. Stimulation by 1,25-dihydroxyvitamin D3 of insulin receptor expression and insulin responsiveness for glucose transport in U-937 human promonocytic cells. Endocr J. 2000; 47: 383-391. PMID: 11075718
57. Saito H, Takeda S, Amizuka N. Eldecalcitol and calcitriol stimulates 'bone minimodeling,' focal bone formation without prior bone resorption, in rat trabecular bone. J Steroid Biochem Mol Biol. 2013; 136: 178-182. doi: 10.1016/j.jsbmb.2012.10.004 PMID: 23069645
58. Vieth R. Vitamin D toxicity, policy, and science. J Bone Miner Res. 2007; 22: V64-V68. doi: 10.1359/ jbmr.07s221 PMID: 18290725
59. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999; 69: 842-856. PMID: 10232622
60. Zebger-Gong H, Muller D, Diercke M, Haffner D, Hocher B, Verberckmoes S, et al. 1,25-Dihydroxyvitamin D3-induced aortic calcifications in experimental uremia: Up-regulation of osteoblast markers, calcium-transporting proteins and osterix. J Hypertens. 2011; 29: 339-348. doi: 10.1097/HJH. 0b013e328340aa30 PMID: 21063202
61. Mortensen JT, Brinck P, Binderup L. Toxicity of vitamin D analogues in rats fed diets with standard or low calcium contents. Pharmacol Toxicol. 1993; 72: 124-127. PMID: 8474965
62. Bas A, Lopez I, Perez J, Rodriguez M, Aguilera-Tejero E. Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function. J Bone Miner Res. 2006; 21: 484-490. PMID: 16491297
63. Atchison DK, Harding P, Beierwaltes WH. Vitamin D increases plasma renin activity independently of plasma Ca2+ via hypovolemia and beta-adrenergic activity. Am J Physiol Renal Physiol. 2013; 305: F1109-F1117. doi: 10.1152/ajprenal.00010.2013 PMID: 23926179
64. Stucchi P, Cano V, Ruiz-Gayo M, Fernandez-Alfonso MS. Aliskiren reduces body-weight gain, adiposity and plasma leptin during diet-induced obesity. Br J Pharmacol. 2009; 158: 771-778. doi: 10.1111/j. 1476-5381.2009.00355.x PMID: 19694726
65. Arunabh S, Pollack S, Yeh J, Aloia JF. Body fat content and 25-hydroxyvitamin D levels in healthy women. J Clin Endocrinol Metab. 2003; 88: 157-161. PMID: 12519845
66. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J, et al. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab. 2004; 89: 1196-1199. PMID: 15001609
67. Frigolet ME, Torres N, Tovar AR. The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity. J Nutr Biochem. 2013; 24: 2003-2015. doi: 10.1016/j.jnutbio.2013.07.002 PMID: 24120291
68. Hwang IS, Huang WC, Wu JN, Shian LR, Reaven GM. Effect of fructose-induced hypertension on the renin-angiotensin-aldosterone system and atrial natriuretic factor. Am J Hypertens. 1989; 2: 424-427. PMID: 2527043